70209-54-0

Basic information

• Product Name: Benzyl-2-acetamido-3,6-di-O-benzyl-2-desoxy-4-O-(β-D-galactopyranosyl)-α-D-glucopyranosid
• Synonyms: Benzyl-2-acetamido-3,6-di-O-benzyl-2-desoxy-4-O-(β-D-galactopyranosyl)-α-D-glucopyranosid
• CAS NO: 70209-54-0
• Molecular Weight: 653.727
• Mol File: 70209-54-0.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzyl-2-acetamido-3,6-di-O-benzyl-2-desoxy-4-O-(β-D-galactopyranosyl)-α-D-glucopyranosid(CAS DataBase Reference)
• NIST Chemistry Reference: Benzyl-2-acetamido-3,6-di-O-benzyl-2-desoxy-4-O-(β-D-galactopyranosyl)-α-D-glucopyranosid(70209-54-0)
• EPA Substance Registry System: Benzyl-2-acetamido-3,6-di-O-benzyl-2-desoxy-4-O-(β-D-galactopyranosyl)-α-D-glucopyranosid(70209-54-0)

Safety Data

• Hazardous Substances Data: 70209-54-0(Hazardous Substances Data)

Upstream product

• 100-39-0 benzyl bromide 
• 3068-32-4 1-bromo-1-deoxy-2,3,4,6-tetra-O-acetyl-a-D-galactopyranoside 
• 55287-49-5 benzyl 2-acetamido-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 14146-27-1 benzyl 3-O-benzyl-2-acetamido-2-deoxy-α-D-glucopyranoside 
• 55287-49-5 benzyl 2-acetamido-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 58700-48-4 Benzyl-2-acetamido-3,6-di-O-benzyl-2-desoxy-4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-α-D-glucopyranosid 

Downstream Products

• 77356-41-3 benzyl 2-acetamido-4-O-(2,6-di-O-benzyl-β-D-galactopyranosyl)-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 70209-58-4 benzyl O-(2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-(1<*>2)-O-(4,6-O-benzylidene-β-D-galactopyranosyl)-(1<*>4)-2-acetamido-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 77016-11-6 benzyl 2-acetamido-3,6-di-O-benzyl-2-deoxy-4-O-(2,3-di-O-benzoyl-4,6-O-benzylidene-β-D-galactopyranosyl)-α-D-glucopyranoside 
• 77016-10-5 benzyl 2-acetamido-3,6-di-O-benzyl-2-deoxy-4-O-(2,3-di-O-acetyl-4,6-O-benzylidene-β-D-galactopyranosyl)-α-D-glucopyranoside 
• 70209-56-2 benzyl 2-acetamido-4-O-(3-O-benzoyl-4,6-O-benzylidene-β-D-galactopyranosyl)-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 70209-57-3 benzyl O-(2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-(1<*>2)-O-(3-O-benzoyl-4,6-O-benzylidene-3-O-benzoyl-β-D-galactopyranosyl)-(1<*>4)-2-acetamido-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 76909-80-3 Benzyl-2-acetamido-3,6-di-O-benzyl-2-desoxy-4-O-(2,3-di-O-benzyl-β-D-galactopyranosyl)-α-D-glucopyranosid 
• 77396-76-0 benzyl 2-acetamido-4-O-(4,6-di-O-acetyl-2,3-di-O-benzyl-β-D-galactopyranosyl)-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 77396-75-9 benzyl 2-acetamido-4-O-(2,3-di-O-benzyl-4,6-O-isopropylidene-β-D-galactopyranosyl)-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 114669-83-9 benzyl 2-acetamido-3,6-di-O-benzyl-2-deoxy-4-O-(2-O-methyl-β-D-galactopyranosyl)-α-D-glucopyranoside 
• 114669-88-4 N-{(2S,3R,4R,5S,6R)-2,4-Bis-benzyloxy-6-benzyloxymethyl-5-[(3aS,4R,6S,7R,7aS)-4-(tert-butyl-diphenyl-silanyloxymethyl)-7-methoxy-2,2-dimethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran-6-yloxy]-tetrahydro-pyran-3-yl}-acetamide 
• 114669-87-3 benzyl 2-acetamido-3,6-di-O-benzyl-4-O-<6-O-(tert-butyldiphenylsilyl)-3,4-O-isopropylidene-β-D-galactopyranosyl>-2-deoxy-α-D-glucopyranoside 
• 114669-86-2 benzyl 2-acetamido-3,6-di-O-benzyl-2-deoxy-4-O-(6-tert-butyldiphenylsilyl-β-D-galactopyranosyl)-α-D-glucopyranoside 
• 77396-74-8 N-[(2S,3R,4R,5S,6R)-2,4-Bis-benzyloxy-6-benzyloxymethyl-5-((3aS,4R,6S,7R,7aR)-7-hydroxy-4-hydroxymethyl-2,2-dimethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran-6-yloxy)-tetrahydro-pyran-3-yl]-acetamide 

Relevant articles and documents

CHEMICAL SYNTHESIS OF THE HUMAN BLOOD-GROUP P1-ANTIGENIC DETERMINANT-

Condensation of known benzyl 2-acetamido-3,6-di-O-benzyl-2-deoxy-4-O-(2,3,6-tri-O-benzyl-β-D-galactopyranosyl)-α-D-glucopyranoside with 2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl chloride in dichlormethane in the presence of 2,4,6-trimethylpyridine, silv

Bausteine von Oligosacchariden, XX. Synthese der Oligosaccharid-Determinanten der Blutgruppensubstanzen der Type 2 des ABH-Systems. Diskussion der &α-Glycosid-Synthese

The antigenic determinants of type 2 of blood-group substances A and B (23 and 24) as well as blood-group substance H (17) were synthesized by selective glycosidation reactions combined with a series of blocking and deblocking steps.The possibilities and optimization of the α-glycoside synthesis are discussed.In hemagglutination inhibition tests the synthetic haptens A and B of type 2 and type 1 show a similar selective inhibitory effect.In case of hapten H, however, great differences can be observed.Here the type 2 exhibited a strong inhibition activity, whereas type 1 only showed an extremly low activity.This leads to the conclusion that in the determinants of the ABH-system on the surface of erythrocytes the chemical structure of type 2 is predominating.